VanEck Biotech ETF (BBH) IV/HV History
Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.
VanEck Biotech ETF (BBH) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $369.1M, listed on NASDAQ, carrying a beta of 0.60 to the broader market. VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. public since 1999-11-23.
Snapshot as of May 15, 2026.
- Spot Price
- $182.24
- ATM IV
- 21.9%
- HV 20-Day
- 19.3%
- HV 60-Day
- 21.5%
- IV Rank
- 28.2%
- IV Percentile
- 55.6%
As of May 15, 2026, VanEck Biotech ETF (BBH) ATM implied volatility is 21.9%. 20-day realized volatility is 19.3%, producing an IV-HV spread of +2.6 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 28.2%.
How BBH iv/hv history Data Feeds Strategy Selection
Strategy selection on VanEck Biotech ETF options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 21.9% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how implied vs realized volatility is reported and how to read the data →
Frequently asked BBH iv/hv history questions
- Is BBH options pricing rich or cheap right now?
- As of May 15, 2026, VanEck Biotech ETF (BBH) ATM IV is 21.9% against 20-day realized volatility of 19.3%. IV rank is 28.2%. BBH options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 2.6 vol points.
- What is the BBH variance risk premium?
- The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. BBH is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
- What does BBH IV rank mean for strategy selection?
- IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. BBH's current rank of 28.2% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.